Metraipolis › archive › dc_b2d28cc2d03b

Systems-level analyses and clinical validation highlight CD53 as a diagnostic and prognostic marker in lung adenocarcinoma — Europe PMC PMID:42368459

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42368459
DOI
10.3389/fcell.2026.1806566
License (as archived)
solo-consultazione
Archived
2026-10-31T13:50:46.734Z
SHA-256 of the archived text
a6f98d99a423e0d57e45439bd2685165b2d31be0355b89f9ebf804b888110927
Stable URL of this page
https://metraipolis.com/documento/dc_b2d28cc2d03b

How to cite

Systems-level analyses and clinical validation highlight CD53 as a diagnostic and prognostic marker in lung adenocarcinoma — Europe PMC PMID:42368459 — Europe PMC (en), https://europepmc.org/article/MED/42368459 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b2d28cc2d03b (Metraipolis archive dc_b2d28cc2d03b, sha256 a6f98d99a423e0d57e45439bd2685165b2d31be0355b89f9ebf804b888110927)
BibTeX
@misc{dcb2d28cc2d03b,
  title = {Systems-level analyses and clinical validation highlight CD53 as a diagnostic and prognostic marker in lung adenocarcinoma — Europe PMC PMID:42368459},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42368459},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b2d28cc2d03b; sha256 a6f98d99a423e0d57e45439bd2685165b2d31be0355b89f9ebf804b888110927},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42368459. Agents can read the archived copy with the MCP tool read_document.